Nurotron Biotechnology Wins Tender

News provided by

Fagan Business Communications

Dec 01, 2015, 03:00 ET

HANGZHOU, China (PRWEB) December 01, 2015 -- Nurotron Biotechnology Co., Ltd., maker of cochlear implant systems, has won a tender that will result in its largest order to date.

The order will be from the China Disabled Persons’ Federation, a central government association, for nearly 2,000 cochlear implant systems. Nurotron’s Venus Cochlear Implant System is an effective solution for children and adults suffering from severe and profound hearing loss. The company holds the CE mark in Europe, and has received approval to sell in China, Colombia, India, Turkey and Venezuela as well.

This order is slated for children, age 6 and under, according to Chu Li, CEO of Nurotron. Throughout the next year, hospitals in provinces throughout China will fit children who will benefit from the technology.

Nurotron will manufacture the systems at its existing facilities and its new 323,000-square-foot complex in Zhejiang Hangzhou, China. The new complex, which is scheduled to open in 2016, will increase the company’s space by ten-fold. Staffing will increase by a factor of 10 as well, with Nurotron employing 3,000 at the new facility. The company’s research and development center is located in Irvine, Calif.

“The expansion was designed to position Nurotron for rapid growth and large orders, exactly like this one from the China Disabled Persons’ Federation,” says Li. “Nurotron is poised to provide safe, reliable cochlear implants as demand for the technology grows, and is especially grateful to be able to help so many children in need.”

Nurotron Biotechnology Co., Ltd. (http://en.nurotron.com)
Nurotron Biotechnology is a medical device company that designs, develops and markets cochlear implant systems. The company’s flagship system is the Venus Cochlear Implant System, a safe, reliable and effective solution for children and adults suffering from severe and profound hearing loss. The global leader in cochlear implant technology maintains its research and development center in Irvine, Calif., and manufacturing facilities in China. Founded in 2006, Nurotron is headquartered in Hangzhou, China.

(end)

Aimee Bennett, Fagan Business Communications, http://en.nurotron.com/, +1 303-843-9840, [email protected]